For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
Andrea Brückner
Advertisement
Andrea Brückner is a managing director in Accenture’s Life Sciences practice. She also leads the practice in Europe, Africa and Latin America as well as in Germany, Austria and Switzerland. She has over 12 years consulting experience in the United States and Europe.
Articles by Andrea Brückner
Advertisement
Latest Updated Articles
Investing in Patient-Centric Capabilities Requires a Clear StrategyPublished: May 31st 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
